"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 6 | 2 | 8 |
| 2010 | 4 | 3 | 7 |
| 2011 | 2 | 3 | 5 |
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 5 | 7 |
| 2014 | 5 | 0 | 5 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 3 | 6 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
Kolašinac R, Bier D, Schmitt L, Yabluchanskiy A, Neumaier B, Merkel R, Csiszár A. Delivery of the Radionuclide 131I Using Cationic Fusogenic Liposomes as Nanocarriers. Int J Mol Sci. 2021 Jan 05; 22(1).
-
Sun H, Burrola S, Wu J, Ding WQ. Extracellular Vesicles in the Development of Cancer Therapeutics. Int J Mol Sci. 2020 Aug 24; 21(17).
-
Elechalawar CK, Hossen MN, Shankarappa P, Peer CJ, Figg WD, Robertson JD, Bhattacharya R, Mukherjee P. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Int J Nanomedicine. 2020; 15:991-1003.
-
Chen J, Shi X, Zhu Y, Chen Y, Gao M, Gao H, Liu L, Wang L, Mao C, Wang Y. On-demand storage and release of antimicrobial peptides using Pandora's box-like nanotubes gated with a bacterial infection-responsive polymer. Theranostics. 2020; 10(1):109-122.
-
Yang M, Yang T, Mao C. Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors. Angew Chem Int Ed Engl. 2019 10 01; 58(40):14066-14080.
-
Mirniaharikandehei S, VanOsdol J, Heidari M, Danala G, Sethuraman SN, Ranjan A, Zheng B. Developing a Quantitative Ultrasound Image Feature Analysis Scheme to Assess Tumor Treatment Efficacy Using a Mouse Model. Sci Rep. 2019 05 13; 9(1):7293.
-
Au JL, Lu Z, Abbiati RA, Wientjes MG. Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products. AAPS J. 2019 02 01; 21(2):24.
-
Dai Q, Wilhelm S, Ding D, Syed AM, Sindhwani S, Zhang Y, Chen YY, MacMillan P, Chan WCW. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. ACS Nano. 2018 08 28; 12(8):8423-8435.
-
Yang M, Li Y, Huai Y, Wang C, Yi W, Mao C. Evolutionary selection of personalized melanoma cell/tissue dual-homing peptides for guiding bionanofibers to malignant tumors. Chem Commun (Camb). 2018 Feb 08; 54(13):1631-1634.
-
Cao B, Xu H, Yang M, Mao C. Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy. Methods Mol Biol. 2018; 1776:643-652.